MedPath

Clinical study on Bushen Huoxue Decoction in the treatment of peripheral neuropathy of multiple myeloma

Phase 1
Not yet recruiting
Conditions
multiple myeloma
Registration Number
ITMCTR2000003809
Lead Sponsor
Shanghai municipal Hospital of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1) Multiple myeloma peripheral neuropathy was diagnosed;
2) Aged between 25 and 85 years old;
3) Conscious and willing to accept the trial treatment.

Exclusion Criteria

1) Those who do not meet the inclusion criteria;
2) Those who are allergic to the test drug;
3) Patients with important organ dysfunction and mental disorders;
4) Participants in other clinical drug trials;
5) Those who suffer from mental illness or mental disorder and cannot be controlled.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Ā© 2025 MedPath, Inc. All rights reserved.